Global Liquid Biopsy Market Forecast Reveals a 15.2% CAGR Growth Through 2035 Amid Rising Demand for Non Invasive Cancer Diagnostics - ResearchAndMarkets.com
The global liquid biopsy market is projected to expand significantly, exhibiting a robust compounded annual growth rate (CAGR) of 15.2% through the year 2035.
- The global liquid biopsy market is projected to expand significantly, exhibiting a robust compounded annual growth rate (CAGR) of 15.2% through the year 2035.
- The report underlines key factors propelling market growth, including the increasing demand for early cancer detection and the surging inclination toward non invasive diagnostic methods.
- Liquid biopsy is hailed as a transformative approach in this research domain, especially for its targets in non invasive cancer diagnosis, patient monitoring, and precision medicine.
- North America holds a significant share of the liquid biopsy market, with numerous companies actively investing in research and development.